The future of healthcare: the patient advocate and investor perspectives
Gilead, Hep C, hepatitis C, HIV, Investor perspective, patient centricity, patient engagement, patients, R&D
0 Comment
Examining the views of different stakeholders in the ecosystem supporting drug R&D.